Morphology and levonorgestrel release behavior of polycaprolactone/ poly(ethylene oxide)/Polylactide tri‐component copolymeric microspheres
- 1 March 2003
- journal article
- research article
- Published by Wiley in Polymers for Advanced Technologies
- Vol. 14 (3-5) , 239-244
- https://doi.org/10.1002/pat.300
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devicesBiomaterials, 2000
- Hydrolytic degradation of polyester-polyether block copolymer based on polycaprolactone/poly(ethylene glycol)/polylactidePolymers for Advanced Technologies, 2000
- Nanosphere based oral insulin deliveryPublished by Elsevier ,2000
- Polylactones 48. SnOct2-Initiated Polymerizations of Lactide: A Mechanistic StudyMacromolecules, 2000
- Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(d,l-lactide) block copolymers as potential drug carrierJournal of Controlled Release, 1999
- Synthesis and characterization of polycaprolactone / poly(ethylene oxide) / polylactide tri-component copolymersJournal of Biomaterials Science, Polymer Edition, 1999
- The control of protein release from poly(dl-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water methodJournal of Controlled Release, 1998
- Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release propertiesJournal of Microencapsulation, 1990
- Controlled drug release from poly(ortho esters) — A surface eroding polymerJournal of Controlled Release, 1985
- Controlled release of biologically active compounds from bioerodible polymersBiomaterials, 1980